The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Phytonadione
Phytonadione · PHYTONADIONE 5 mg/1 · Tablet · Oral · ScieGen Pharmaceuticals Inc
NDC 50228-0333-01 · 1 BOTTLE in 1 CARTON / 100 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for phytonadione (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- ScieGen Pharmaceuticals, INC.United Statesanalysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA213329
- TE code
- AB
- Approval date
- Jul 28, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Phytonadione (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Agnitio Inc. | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals NY LLC | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA., Inc. | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Coupler LLC | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Exelan Pharmaceuticals, Inc. | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC. | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ScieGen Pharmaceuticals Inc | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | PHYTONADIONE 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Phytonadione — NDC 50228-0333-01," retrieved September 3, 2026, https://drugdashboards.com/drug/50228033301.
Free to cite with attribution — see how the data is put together.